Protein biosynthesis, a target of sorafenib, interferes with the unfolded protein response (UPR) and ferroptosis in hepatocellular carcinoma cells. (Q50321414)
Jump to navigation
Jump to search
scientific article published on 3 January 2018
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Protein biosynthesis, a target of sorafenib, interferes with the unfolded protein response (UPR) and ferroptosis in hepatocellular carcinoma cells. |
scientific article published on 3 January 2018 |
Statements
1 reference
Protein biosynthesis, a target of sorafenib, interferes with the unfolded protein response (UPR) and ferroptosis in hepatocellular carcinoma cells. (English)
1 reference
Chloé Sauzay
1 reference
Christophe Louandre
1 reference
Sandra Bodeau
1 reference
Frédéric Anglade
1 reference
Corinne Godin
1 reference
Zuzana Saidak
1 reference
Jean-Xavier Fontaine
1 reference
Cédric Usureau
1 reference
Nathalie Martin
1 reference
Roland Molinie
1 reference
Julie Pascal
1 reference
François Mesnard
1 reference
Olivier Pluquet
1 reference
Antoine Galmiche
1 reference
3 January 2018
1 reference
1 reference
9
1 reference
9
1 reference
8400-8414
1 reference
Identifiers
1 reference
1 reference
1 reference